Epidermal growth factor-urogastrone causes vasodilatation in the anesthetized dog.
Epidermal growth factor-urogastrone (EGF-URO) administered intraarterially was a potent dilator in dog femoral (FEM), superior (cephalic) mesenteric (SMA), celiac (CAC), coronary (COR), carotid (CAR), and renal (REN) vascular beds. The effects of EGF-URO, which exhibited tachyphylaxis, could not be...
Na minha lista:
| Publicado no: | J Clin Invest |
|---|---|
| Principais autores: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Clinical Investigation
1987
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC442219/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3496362/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI113048 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|